Here are the DEF 14A proxy statements from Jupiter Neurosciences, Inc. (JUNS) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow JUNS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full JUNS filings page.
Jupiter Neurosciences is calling a virtual annual meeting on July 22, 2026 to vote on key governance items. Stockholders will elect seven directors, including two new nominees, and ratify Cherry Bekaert LLP as auditor for the year ending December 31, 2026.
They will also vote on increasing the 2025 Equity Incentive Plan share pool by 5,250,000 common shares and on a reverse stock split at a ratio between 1:10 and 1:100, with the exact ratio and timing left to the board’s discretion. The proxy details director independence, committee structures, and 2025 executive pay, including equity awards tied to the 2024 IPO and prior salary reductions.